Common Contracts

1 similar null contracts

BVXV: Definitive Collaboration Agreement Signed to Develop Pipeline of NanoAb
May 2nd, 2022
  • Filed
    May 2nd, 2022

Based on our probability adjusted DCF model that takes into account potential future revenues from the NanoAb platform, BVXV is valued at $12.00/ADS. This model is highly dependent upon continued clinical success of NanoAb candidates and will be adjusted accordingly based upon future clinical results.

AutoNDA by SimpleDocs
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!